HER2-CD3-Fc Bispecific Antibody-Encoding mRNA Delivered by Lipid Nanoparticles Suppresses HER2-Positive Tumor Growth

The human epidermal growth factor receptor 2 (HER2) is a transmembrane tyrosine kinase receptor and tumor-associated antigen abnormally expressed in various types of cancer, including breast, ovarian, and gastric cancer. HER2 overexpression is highly correlated with increased tumor aggressiveness, p...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Liang Hu, Shiming Zhang, John Sienkiewicz, Hua Zhou, Robert Berahovich, Jinying Sun, Michael Li, Adrian Ocampo, Xianghong Liu, Yanwei Huang, Hizkia Harto, Shirley Xu, Vita Golubovskaya, Lijun Wu
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2024-07-01
Serie:	Vaccines
Soggetti:	HER2 cancer bispecific antibody CD3 lipid nanoparticle immunotherapy
Accesso online:	https://www.mdpi.com/2076-393X/12/7/808
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!